PLATINUM INVESTMENT MANAGEMENT LTD - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$3,125,727
-35.2%
3,189,517
-8.1%
0.12%
-26.9%
Q2 2023$4,822,791
+17.5%
3,469,634
+34.5%
0.17%
+17.6%
Q1 2023$4,103,114
-53.9%
2,580,575
+80.5%
0.14%
-58.2%
Q4 2022$8,908,906
-7.0%
1,430,0010.0%0.34%
-15.0%
Q3 2022$9,581,000
-7.2%
1,430,001
-11.9%
0.40%
+2.6%
Q2 2022$10,325,000
-18.0%
1,623,440
-40.2%
0.39%
+1.0%
Q1 2022$12,589,000
-7.2%
2,713,1760.0%0.39%
+2.1%
Q4 2021$13,566,000
-34.3%
2,713,176
+58.4%
0.38%
-34.9%
Q3 2021$20,644,000
-43.0%
1,713,1760.0%0.58%
-30.7%
Q2 2021$36,234,000
-19.3%
1,713,176
+7.0%
0.84%
-16.4%
Q1 2021$44,897,000
+10.5%
1,600,613
+2.4%
1.00%
+7.3%
Q4 2020$40,635,000
+26.1%
1,562,869
+80.3%
0.93%
+17.2%
Q3 2020$32,215,000
-26.3%
866,681
+1.8%
0.80%
-20.1%
Q2 2020$43,688,000
+70.7%
851,453
+4.9%
1.00%
+54.3%
Q1 2020$25,593,000
+1016.1%
811,692
+2010.8%
0.65%
+1335.6%
Q4 2019$2,293,00038,4540.04%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$69,675,00019.39%
Endurant Capital Management LP 207,293$5,390,0001.94%
Bellevue Group AG 5,138,451$133,599,0001.53%
Rhenman & Partners Asset Management AB 592,225$15,398,0001.26%
PLATINUM INVESTMENT MANAGEMENT LTD 1,562,869$40,635,0000.93%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 31,434$817,0000.62%
WASATCH ADVISORS LP 3,998,010$103,949,0000.51%
HAMILTON LANE ADVISORS LLC 46,181$1,201,0000.45%
Boxer Capital, LLC 500,000$13,000,0000.42%
DCF Advisers, LLC 38,500$1,001,0000.41%
View complete list of ESPERION THERAPEUTICS INC NE shareholders